Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999 Aug 2;190(3):301-6.
doi: 10.1084/jem.190.3.301.

CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation

S Iwata  1 , C Morimoto
Affiliations
Review

CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation

S Iwata et al. J Exp Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic view: complexity of the site of action and clinical significance of CD26/DPPIV. CD26/DPPIV is a multifunctional ectoenzyme that may elicit biological effects on various aspects of development and progression of malignancy. The scheme summarizes some of these effects, including modulation of growth factors and adenosine, alteration of immunosurveillance, promotion of cellular invasion, and metastasis.
See this image and copyright information in PMC

Comment on

References

    1. Morimoto C., Schlossman S.F. The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 1998;161:55–70. - PubMed
    1. Wesley U.V., Albino A.P., Tiwari S., Houghton A.N. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanoma cells. J. Exp. Med. 1999;190:311–322. - PMC - PubMed
    1. Morrison M.E., Vijayasaradhi S., Engelstein D., Albino A.P., Houghton A.N. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J. Exp. Med. 1993;177:1135–1143. - PMC - PubMed
    1. Shipp M.A., Look A.T. Hematopoietic differentiation antigens that are membrane-associated enzymescutting is the key! Blood. 1993;82:1052–1070. - PubMed
    1. Papandreou C.N., Usmani B., Geng Y., Bogenrieder T., Freeman R., Wilk S., Finstad C.L., Reuter V.E., Powell C.T., Scheinberg D. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat. Med. 1998;1:50–57. - PubMed

MeSH terms

Substances